X

Health Care

NATCO Pharma Limited (NATCOPHARM) Q3 FY23 Earnings Concall Transcript

NATCO Pharma Limited (NSE:NATCOPHARM) Q3 FY23 Earnings Concall dated Feb. 10, 2023. Corporate Participants: Rajesh Chebiyam -- Executive Vice President of Crop…

Aurobindo Pharma Limited (AUROPHARMA) Q3 FY23 Earnings Concall Transcript

Aurobindo Pharma Limited (NSE:AUROPHARMA) Q3 FY23 Earnings Concall dated Feb. 10, 2023. Corporate Participants: Deepti Thakur -- Investor Relations Santhanam Subramanian -- Chief Financial…

Healthcare Global Enterprises Ltd (HCG) Q3 FY23 Earnings Concall Transcript

Healthcare Global Enterprises Ltd (NSE:HCG) Q3 FY23 Earnings Concall dated Feb. 09, 2023. Corporate Participants: BS Ajai Kumar -- Executive Chairman Raj…

Windlas Biotech Limited (WINDLAS) Q3 FY23 Earnings Concall Transcript

Windlas Biotech Limited (NSE:WINDLAS) Q3 FY23 Earnings Concall dated Feb. 09, 2023. Corporate Participants: Hitesh Windlas -- Managing Director Komal Gupta -- Chief Executive…

ABBOTT INDIA LTD Ltd. (NSE: ABBOTTINDIA): Q3 FY23 Results Out; Total Income Rises 10% YoY

Abbott India Limited (NSE:ABBOTTINDIA) is a subsidiary of Abbott Laboratories, a multinational healthcare company. It was established in India in…

Alkem Laboratories Ltd. (NSE: ALKEM): Q3 FY23 Results Out; Total Income Rises 15% YoY

Alkem Laboratories Ltd.(NSE:ALKEM) is a pharmaceutical company that specializes in developing, manufacturing, and marketing of pharmaceutical and nutraceutical products. The…

Zydus lifescience net profit soars by 23% in Q3FY23

Zydus Lifesciences Ltd reported a 23 per cent rise in consolidated net profit at INR 631 crore for the third…

JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) Q3 FY23 Earnings Concall Transcript

JB Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Q3 FY23 Earnings Concall dated Feb. 09, 2023. Corporate Participants: Jason D'Souza -- Vice President, Investor…

Piramal Pharma Ltd (PPLPHARMA) Q3 FY23 Earnings Concall Transcript

Piramal Pharma Ltd (NSE: PPLPHARMA) Q3 FY23 Earnings Concall dated Feb. 09, 2023 Corporate Participants: Gagan Borana -- General Manager, Investor Relations…

Lupin Limited Q3FY23; 47% Growth in Profits

Lupin Limited’s revenue in Q3FY23 rose 13% to ₹ 1,97,66,301 lakhs. Consolidated Profit After Tax came at ₹ 8,34,871 lakhs…